Chief Sponsor: Curtis S. Bramble

House Sponsor: Mike Schultz


8     General Description:
9          This bill enacts provisions related to testing and the collection and use of data relating
10     to populations at high risk for COVID-19.
11     Highlighted Provisions:
12          This bill:
13          ▸     allows the Department of Health and local health departments to share certain data
14     regarding COVID-19 patients with state agencies for analysis;
15          ▸     enacts provisions relating to COVID-19 testing of certain individuals at care
16     facilities; and
17          ▸     requires the Department of Health to collect and publish information relating to risk
18     factors for COVID-19.
19     Money Appropriated in this Bill:
20          None
21     Other Special Clauses:
22          This bill provides a special effective date.
23     Utah Code Sections Affected:
24     AMENDS:
25          26-6-27, as last amended by Laws of Utah 2012, Chapters 150 and 391
26     ENACTS:
27          26-6-32, Utah Code Annotated 1953


29     Be it enacted by the Legislature of the state of Utah:
30          Section 1. Section 26-6-27 is amended to read:
31          26-6-27. Information regarding communicable or reportable diseases
32     confidentiality -- Exceptions.
33          (1) Information collected pursuant to this chapter in the possession of the department
34     or local health departments relating to an individual who has or is suspected of having a disease
35     designated by the department as a communicable or reportable disease under this chapter shall
36     be held by the department and local health departments as strictly confidential. The department
37     and local health departments may not release or make public that information upon subpoena,
38     search warrant, discovery proceedings, or otherwise, except as provided by this section.
39          (2) The information described in Subsection (1) may be released by the department or
40     local health departments only in accordance with the requirements of this chapter and as
41     follows:
42          (a) specific medical or epidemiological information may be released with the written
43     consent of the individual identified in that information or, if that individual is deceased, his
44     next-of-kin;
45          (b) specific medical or epidemiological information may be released to medical
46     personnel or peace officers in a medical emergency, as determined by the department in
47     accordance with guidelines it has established, only to the extent necessary to protect the health
48     or life of the individual identified in the information, or of the attending medical personnel or
49     law enforcement or public safety officers;
50          (c) specific medical or epidemiological information may be released to authorized
51     personnel within the department, local health departments, public health authorities, official
52     health agencies in other states, the United States Public Health Service, the Centers for Disease
53     Control and Prevention (CDC), or when necessary to continue patient services or to undertake
54     public health efforts to interrupt the transmission of disease;
55          (d) if the individual identified in the information is under the age of 18, the information
56     may be released to the Division of Child and Family Services within the Department of Human
57     Services in accordance with Section 62A-4a-403. If that information is required in a court
58     proceeding involving child abuse or sexual abuse under Title 76, Chapter 5, Offenses Against

59     the Person, the information shall be disclosed in camera and sealed by the court upon
60     conclusion of the proceedings;
61          (e) specific medical or epidemiological information may be released to authorized
62     personnel in the department or in local health departments, and to the courts, to carry out the
63     provisions of this title, and rules adopted by the department in accordance with this title;
64          (f) specific medical or epidemiological information may be released to blood banks,
65     organ and tissue banks, and similar institutions for the purpose of identifying individuals with
66     communicable diseases. The department may, by rule, designate the diseases about which
67     information may be disclosed under this subsection, and may choose to release the name of an
68     infected individual to those organizations without disclosing the specific disease;
69          (g) specific medical or epidemiological information may be released in such a way that
70     no individual is identifiable;
71          (h) specific medical or epidemiological information may be released to a "health care
72     provider" as defined in Section 78B-3-403, health care personnel, and public health personnel
73     who have a legitimate need to have access to the information in order to assist the patient, or to
74     protect the health of others closely associated with the patient;
75          (i) specific medical or epidemiological information regarding a health care provider, as
76     defined in Section 78B-3-403, may be released to the department, the appropriate local health
77     department, and the Division of Occupational and Professional Licensing within the
78     Department of Commerce, if the identified health care provider is endangering the safety or life
79     of any individual by his continued practice of health care; [and]
80          (j) specific medical or epidemiological information may be released in accordance with
81     Section 26-6-31 if an individual is not identifiable[.]; and
82          (k) specific medical or epidemiological information may be released to a state agency
83     as defined in Section 67-25-102, to perform the analysis described in Subsection 26-6-32(4) if
84     the state agency agrees to act in accordance with the requirements in this chapter.
85          (3) The provisions of Subsection (2)(h) do not create a duty to warn third parties, but is
86     intended only to aid health care providers in their treatment and containment of infectious
87     disease.
88          Section 2. Section 26-6-32 is enacted to read:
89          26-6-32. Testing for COVID-19 for high-risk individuals at care facilities --

90     Collection and release of information regarding risk factors and comorbidities for
91     COVID-19.
92          (1) As used in this section:
93          (a) "Care facility" means a facility described in Subsections 26-6-6(2) through (6).
94          (b) "COVID-19" means the same as that term is defined in Section 78B-4-517.
95          (2) (a) At the request of the department or a local health department, an individual who
96     meets the criteria established by the department under Subsection (2)(b) shall submit to testing
97     for COVID-19.
98          (b) The department:
99          (i) shall establish protocols to identify and test individuals who are present at a care
100     facility and are at high risk for contracting COVID-19;
101          (ii) may establish criteria to identify care facilities where individuals are at high risk for
102     COVID-19; and
103          (iii) may establish who is responsible for the costs of the testing.
104          (c) (i) The protocols described in Subsection (2)(b)(i) shall:
105          (A) notwithstanding Subsection (2)(a), permit an individual who is a resident of a care
106     facility to refuse testing; and
107          (B) specify criteria for when an individual's refusal to submit to testing under
108     Subsection (2)(c)(i)(A) endangers the health or safety of other individuals at the care facility.
109          (ii) Notwithstanding any other provision of state law, a care facility may discharge a
110     resident who declines testing requested by the department under Subsection (2)(a) if:
111          (A) under the criteria specified by the department under Subsection (2)(c)(i)(B), the
112     resident's refusal to submit to testing endangers the health or safety of other individuals at the
113     care facility; and
114          (B) discharging the resident does not violate federal law.
115          (3) The department may establish protocols to collect information regarding the
116     individual's age and relevant comorbidities from an individual who receives a positive test
117     result for COVID-19.
118          (4) (a) The department shall publish deidentified information regarding comorbidities
119     and other risk factors for COVID-19 in a manner that is accessible to the public.
120          (b) The department may work with a state agency as defined in Section 67-25-102, to

121     perform the analysis or publish the information described in Subsection (4)(a).
122          Section 3. Effective date.
123          If approved by two-thirds of all the members elected to each house, this bill takes effect
124     upon approval by the governor, or the day following the constitutional time limit of Utah
125     Constitution, Article VII, Section 8, without the governor's signature, or in the case of a veto,
126     the date of veto override.